Pheiron
The AI engine Fit Assessment
BetaPheiron leverages machine learning to discover patterns and develop targeted therapeutics, while also focusing on biomarker identification for personalized medicine.
Blurb
Pheiron offers a data-driven platform for health management, enhancing drug development with AI and causal insights.
HQ Location
Berlin (Germany)
Founded
2023
Employees
1 - 10
Total funding raised
Not available
Last Funding Event
Not available
Smart insights
- Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
- Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
- 6m headcount growth: 25%
- 1Y headcount growth: 94%
- Headcount-to-last-round ratio: 5.3 employees/$M
Subspaces
- Biomarker Identification
Developer of a phenotyping platform intended to decode disease to advance new therapies. The company's platform generates digital biomarkers for the interpretation of biomedical data, transforms complex biomedical data into actionable insights, and drug development for rare diseases, enabling clients to get drugs for different targeted diseases.